TP53 and breast cancer: Our results demonstrate that EGCG has an inhibitory effect on the proliferation of PBMC as well as the production of IFN-γ by PBMC isolated from breast cancer patients when cultured with the breast cancer peptide antigens Her-2/neu and p53 as well as with the mitogen PHA and with anti-CD3 antibodies.